1 Min Read
May 10 (Reuters) - Imprimis Pharmaceuticals Inc:
* Total revenue $6.1 million in the first quarter of 2017, up 39%
* Q1 loss per share $0.26 Source text: (bit.ly/2qUeEi1) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.